This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.
This is a $80,400.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Axon Medchem B.V., a foreign-owned for-profit organization. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, which aims to provide small molecule compounds. The contract has an ultimate completion date of July 25, 2015 and was awarded on April 24, 2015. There was no set-aside designation used for...
<p>This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Biovision Inc., a small disadvantaged business, on April 24, 2015. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, with a ceiling value of $95,640.25 and a completion date of July 25, 2015. The contract does not have a set-aside designation.</p>
<p>This is a $80,750.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Selleck Chemicals LLC, a for-profit limited liability company, on August 12, 2015. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, with an ultimate completion date of November 30, 2015. The contract is not set aside for any special designation. No major subcontractors are mentioned.</p>
This is a $447,635.80 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. government. The contract is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to Analyticon Discovery, LLC, a for-profit foreign-owned organization. The contract does not have a set-aside designation and has an ultimate completion date of January 31, 2016. NCATS is...
<p>The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm-fixed-price purchase order to Chemdiv, Inc. to provide 10,000 proprietary chemical compounds at 8 micromolar each. The total potential value of the award is $128,000.00. The award was not set aside for any specific business type. The contract has a completion date of September 4, 2017.</p>
This federal contract award, with a ceiling value of $1,927,163.66, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The contract was awarded to SRI International, a non-profit research and development organization, and is part of NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract, which is a Delivery Order under the PTNP Indefinite Delivery Vehicle (IDV), is for IND-enabling studies....
This federal contract award, identified as 75N95018P00712, was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to Molport SIA, a for-profit limited liability company located in Latvia. The contract, valued at $51,771.73, is for the purchase of a Chemical Library of 216 small molecule compounds. The contract is a firm fixed-price purchase order with an ultimate completion date of January 31, 2019. The contract was awarded on September 20, 2018, following a pre-solicitation...
<p>The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $104,870.00 firm fixed price purchase order contract to Life Chemicals Inc., a for-profit organization, for services to be performed in Canada. The contract was not set aside for any special designation. The award was made on September 7, 2017, with a completion date of November 1, 2017.</p>
<p>This is a $18,963.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to NINDS PHARMAC LLC for medicinal chemistry consulting services. The contract has a Total Small Business set-aside designation. The contract was awarded on January 12, 2017 and has an ultimate completion date of January 12, 2022. The place of performance is Bethesda, Maryland.</p>